tiprankstipranks
Advertisement
Advertisement

HK:3880 Stock Latest News

Medtide Schedules Board Meeting to Approve 2026 Interim Results
Company AnnouncementsMedtide Schedules Board Meeting to Approve 2026 Interim Results
3d ago
3880
Medtide Warns of Sharply Lower Interim Profit but Stresses Order Backlog Strength
PremiumCompany Announcements
Medtide Warns of Sharply Lower Interim Profit but Stresses Order Backlog Strength
20d ago
3880
Medtide Revamps Finance Leadership and Governance Structure
PremiumCompany Announcements
Medtide Revamps Finance Leadership and Governance Structure
20d ago
3880
Medtide Unit Clears U.S. FDA Inspection for Hepcludex API, Bolstering HDV Treatment Role
PremiumCompany Announcements
Medtide Unit Clears U.S. FDA Inspection for Hepcludex API, Bolstering HDV Treatment Role
20d ago
3880
Medtide shareholders unanimously back board, reports at 2025 AGM
PremiumCompany Announcements
Medtide shareholders unanimously back board, reports at 2025 AGM
2M ago
3880
Medtide to Invest USD22.7 Million in U.S. Peptide Plant Expansion
PremiumCompany AnnouncementsMedtide to Invest USD22.7 Million in U.S. Peptide Plant Expansion
2M ago
3880
Medtide Sets 2025 AGM to Vote on Board, Auditors and 10% H-Share Buyback Mandate
Premium
Company Announcements
Medtide Sets 2025 AGM to Vote on Board, Auditors and 10% H-Share Buyback Mandate
3M ago
3880
Medtide Profits Surge as Peptide Capacity and Global Certifications Expand
Premium
Company Announcements
Medtide Profits Surge as Peptide Capacity and Global Certifications Expand
5M ago
3880
Medtide Moves to Scrap Supervisory Committee as It Aligns Governance with New PRC Company Law
PremiumCompany Announcements
Medtide Moves to Scrap Supervisory Committee as It Aligns Governance with New PRC Company Law
5M ago
3880
Medtide Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
PremiumCompany Announcements
Medtide Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
5M ago
3880
Medtide Completes Full Circulation Conversion of All Shares Into H Shares
PremiumCompany Announcements
Medtide Completes Full Circulation Conversion of All Shares Into H Shares
5M ago
3880
Medtide Signals Sharp 2025 Profit Surge on Peptide Demand and Efficiency Gains
PremiumCompany Announcements
Medtide Signals Sharp 2025 Profit Surge on Peptide Demand and Efficiency Gains
6M ago
3880
Medtide Secures CSRC Filing for H Share Full Circulation Plan
PremiumCompany AnnouncementsMedtide Secures CSRC Filing for H Share Full Circulation Plan
7M ago
3880
Medtide Inc. Announces Key Corporate Secretary Changes
Premium
Company Announcements
Medtide Inc. Announces Key Corporate Secretary Changes
11M ago
3880
Medtide Inc. Reports Robust Growth and Strategic Expansion in 2025
Premium
Company Announcements
Medtide Inc. Reports Robust Growth and Strategic Expansion in 2025
12M ago
3880
Medtide Inc. Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Medtide Inc. Schedules Board Meeting for Interim Results
1y ago
3880
Medtide Inc. Gains CSRC Approval for H Share Full Circulation
PremiumCompany Announcements
Medtide Inc. Gains CSRC Approval for H Share Full Circulation
1y ago
3880

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >